Humana Inc Stock Fair Value Calculator – Humana Demonstrates Strength and Performance in Challenging Economic and Inflationary Environment
January 27, 2023
Trending News ☀️
Humana Inc Stock Fair Value Calculator – Humana Inc ($NYSE:HUM). is a leading health and wellness company in the United States. It offers a variety of services to help individuals stay healthy, including medical, dental, vision, and pharmacy benefits as well as health education and prevention programs. Despite the challenging economic environment caused by Covid-19 and the current global inflationary situation, Humana has proven to be a strong and resilient company. This growth is driven by their ability to provide cost-effective health care solutions to their members.
Additionally, the company has recently implemented a number of initiatives to help individuals stay healthy and manage their health care costs, such as virtual visits, telehealth services, and personalized health and wellness plans. The company has also been focused on expanding its reach by offering more services and products to its members, such as virtual fitness classes, nutrition and weight management programs, and new technology-based solutions. These strategies have enabled Humana to stay competitive in the face of economic uncertainty and low consumer spending. In addition to its strong performance, Humana continues to be an active participant in the community. The company has donated millions of dollars to charities and other organizations that focus on helping people in need. Additionally, Humana has invested heavily in research and development to create innovative solutions that improve the lives of their members. The company continues to focus on providing cost-effective solutions for its members while making meaningful contributions to the community.
Market Price
Despite the uncertainty, media coverage of the healthcare giant has largely been positive. On Monday, Humana Inc stock opened at $498.4 and closed at $494.6, a decrease of 0.6% from the previous closing price of $497.3. This shows that despite the challenging environment, the company has managed to maintain its market value. The success of Humana Inc in the current market is due to its ability to adapt to the changing market conditions due to its well-diversified business portfolio and strong financial position. It has been able to reduce costs and gain new customers in order to remain profitable. Its diversified portfolio of businesses, including Medicare, Medicaid, and commercial health plans, have enabled it to maintain its market share despite economic and inflationary pressures.
Humana Inc has also shown its commitment to innovation and technology, investing heavily in research and development in order to stay ahead of the competition. This has enabled the company to develop innovative products and services that offer value to its customers. Furthermore, the company has also invested in infrastructure that allows for more efficient delivery of services and better customer experience. Despite the challenging market conditions, the company has managed to remain profitable and maintain its market value. This is a true demonstration of the company’s resilience and ability to succeed in tough times. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Humana Inc. More…
| Total Revenues | Net Income | Net Margin |
| 91.48k | 2.81k | 2.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Humana Inc. More…
| Operations | Investing | Financing |
| 9.62k | -96 | -268 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Humana Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 50.77k | 34.45k | 128.39 |
Key Ratios Snapshot
Some of the financial key ratios for Humana Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 13.4% | – | 4.3% |
| FCF Margin | ROE | ROA |
| 9.2% | 15.6% | 4.9% |
VI Analysis – Humana Inc Stock Fair Value Calculator
HUMANA INC stock is currently trading at a fair price of $494.6, which is slightly overvalued by 1%. This can be assessed using the VI app, which provides a quick and easy way to analyze the company’s fundamentals. The VI Line tool calculates the intrinsic value of HUMANA INC shares to be around $491.6. This suggests that the stock is overvalued, although not by a significant amount. Investors should be mindful of the company’s fundamentals when making their decisions. A company with strong fundamentals, such as HUMANA INC, is likely to have a long-term potential. The company’s balance sheet, income statement, and cash flow should all be assessed to determine whether it is a good long-term investment. The company’s financial performance should also be monitored to ensure that it remains profitable and competitive in the market. In conclusion, HUMANA INC stock is currently trading at a fair price, slightly overvalued by 1%. Investors should take into account the company’s fundamentals and financial performance when making their decisions, as this will help them to determine whether or not the stock is a good long-term investment. More…
VI Peers
In the ever-changing world of healthcare, Humana Inc. has been a leader in providing quality services to its customers. However, the company faces stiff competition from the likes of UnitedHealth Group Inc, Cigna Corp, and Oscar Health Inc. All of these companies are striving to provide the best possible healthcare experience to their customers.
– UnitedHealth Group Inc ($NYSE:UNH)
UnitedHealth Group Inc. is an American for-profit managed health care company based in Minnetonka, Minnesota. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. The company offers health care products and services through two operating businesses: UnitedHealthcare and Optum.
UnitedHealthcare provides health benefits and services to individuals, families, and businesses through a wide array of plans and programs, including health insurance, pharmacy benefits, vision, dental, and other supplemental health and wellness benefits. Optum is a health services and innovation company that provides technology-enabled health services and software. It offers healthcare information technology, data analytics, and research and consulting services to the healthcare industry.
The company has a market capitalization of $488.16 billion as of April 2021 and a return on equity of 21.75%.
– Cigna Corp ($NYSE:CI)
Cigna Corp is a health services company with a market cap of 88.46 billion as of 2022. The company has a return on equity of 11.01%. Cigna Corp provides medical, dental, disability, life, and other health insurance products and services. The company also offers pharmacy benefit management services.
– Oscar Health Inc ($NYSE:OSCR)
Oscar Health is a technology-driven health insurance company founded in 2012. The company’s mission is to make health insurance simple, transparent, and human.
Oscar uses technology to simplify the health insurance experience for consumers and providers. The company has a suite of tools that helps consumers understand their benefits, find doctors, and estimate the cost of care. For providers, Oscar offers a platform that streamlines claims processing and provides real-time insights into patients’ health insurance benefits.
Oscar Health is headquartered in New York City and is available in nine states: California, Colorado, Florida, Georgia, Illinois, Michigan, New Jersey, New York, and Texas.
Summary
Humana Inc. has demonstrated impressive strength and performance in the face of challenging economic and inflationary environments. Despite the turbulent market conditions, Humana’s stock has been showing steady growth, and the company has seen positive media attention. Analysts have identified Humana as a strong investment opportunity due to its solid balance sheet and revenue growth.
The company has also been praised for its diverse portfolio of products, services, and technology-based solutions. With a focus on innovation and customer experience, Humana is well-positioned to continue its long-term success.
